The titration schedule plays a critical rolegradual dose escalation, as recommended in FDA labeling, allows for physiological adaptation and typically results in fewer and shorter-duration side effects compared to rapid dose increases
Phase 2 trial data showed up to 24 percent weight loss at 48 weeks, suggesting even more potent effects than either semaglutide or tirzepatide alone
If side effects at 1.7 mg are significant, many providers recommend staying at this dose for an additional 4 weeks before attempting the final escalation to 2.4 mg
Your general health, medical history, and any additional prescriptions you might be taking will all be carefully taken into account
In short, non-arteritic anterior ischemic optic neuropathy, which is possibly linked to Ozempic, can cause permanent blindness/vision loss in one eye